Firefighters Preventing Cancer Online Training Program

January 20, 2025 updated by: Patrick J. McGrath, IWK Health Centre

Firefighters Preventing Cancer: Cluster Randomized Trial of an Online Training Program for Cancer Prevention Behaviors in Volunteer Firefighters

The goal of this two-arm, Cluster Randomized Trial is to evaluate an e-health training program for volunteer firefighters to reduce their risk of exposures to carcinogens and to increase their understanding and intentions of behavior towards cancer prevention. One arm will receive an online e-health intervention for six months and the other arm will be considered as a waitlist control group which will be placed on a waitlist and receive the online treatment program some months later.

The project aims to evaluate the firefighters by measurement of current behavior, perceived importance, future behavioral intentions and perceived barriers for implementing decontamination behaviors at baseline, after the intervention and after 3-month follow-up before and after the intervention.

The intervention consists of three components:

  1. a novel health information strategy, 90SecondFire Cancer health letters
  2. a brief on-line course
  3. a problem-solving asynchronous bulletin board to mobilize existing knowledge

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Firefighters face a serious risk of exposure to carcinogens from products of combustion. Modern materials burn hotter and may be even more toxic than older wood construction. Preventing the increased risk of cancer in volunteer firefighters has raised attention as they are more vulnerable to carcinogen exposure.

The goal of this two-arm, Cluster Randomized Trial is to evaluate an e-health training program for volunteer firefighters to reduce their risk of exposures to carcinogens and to increase their understanding and intentions of behavior towards cancer prevention. One arm will receive an online e-health intervention for six months and the other arm will be considered as a waitlist control group which will be placed on a waitlist and receive the online treatment program some months later. Up to 800 volunteer firefighters from approximately 40 volunteer fire departments in Canada will be recruited for both arms.

The project aims to evaluate the firefighters by measurement of current behavior, perceived importance, future behavioral intentions and perceived barriers for implementing decontamination behaviors at baseline, after the intervention and after 3-month follow-up through an online validated survey: Firefighter Exposure to Carcinogens Scale (FECS).

The intervention consists of three components:

  1. a novel health information strategy, 90SecondFire Cancer health letters
  2. a brief on-line course
  3. a problem-solving asynchronous bulletin board to mobilize existing knowledge

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
179

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Canada
    • Nova Scotia
      • Halifax, Nova Scotia, Canada
        • IWK Health Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Departments will be screened to meet the following criteria

  1. Be a Volunteer Department
  2. Be located in Canada
  3. Consent to participate in the study via the Chief or delegate

Participant in the CRT study must meet all the following criteria to be eligible to proceed with the study:

  1. Be a volunteer firefighter
  2. Working for an all-volunteer fire department that has joined the study
  3. Live in Canada
  4. Has access to internet
  5. Be able to read, write and understand English or French
  6. Consent to participate in the study

Exclusion Criteria:

The exclusion for Departments

  1. Not a volunteer Department in other words to be a composite department with some volunteers and some career fire fighters or a department that has not joined the study
  2. Not located in Canada
  3. Not Consent to be in the study via the Chief or delegate

Any of the following criteria will exclude individuals from proceeding to consent:

  1. NOT a volunteer firefighter
  2. Working for a composite department with some volunteers and some career fire fighters or a department that has not joined the study
  3. Does NOT live in Canada
  4. Does not have access to internet
  5. Is NOT able to read, write and understand English or French
  6. Does NOT consent to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention Group

This arm will receive the online e-health intervention for six months.

The intervention consists of three sections:

  1. a novel health information strategy, 90SecondFire Cancer health letters
  2. a brief on-line course
  3. a problem-solving asynchronous bulletin board to mobilize existing knowledge
Behavioral: e-health training program
  1. Health letters, 44 issues of 90SecondFire Cancer health letters delivered twice a week during six months to firefighters by text or email
  2. A problem-solving asynchronous chat room which encourages mutual support and exchange of ideas via a closed asynchronous bulletin board for peer-to-peer support
  3. A brief 45-minute pre-recorded online course; it is intended as a summative exercise rather than providing new information.
No Intervention: waitlist control group
This group will be placed on a waitlist and will receive the online treatment program after six months.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Volunteer Firefighters' Intention to engage in reducing exposure and undertaking decontamination behaviour
Time Frame: Baseline, After 6 month intervention and 3-month follow-up
In order to measure the changes in firefighter's intention during the study, the data will be collected by an online survey: Firefighter Exposure to Carcinogens Scale. The dimensions will be rated on a Likert scale. min :0 Max 4 ; The higher score does not mean a better outcome.
Baseline, After 6 month intervention and 3-month follow-up

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Volunteer Firefighters' practice and perceived importance towards reducing exposure and undertaking decontamination behavior for cancer prevention
Time Frame: Baseline, After 6 month intervention and 3-month follow-up
The data will be collected by an online survey: Firefighter Exposure to Carcinogens Scale . The dimensions will be rated on a Likert scale. min :0 Max 4 ; The higher score does not mean a better outcome.
Baseline, After 6 month intervention and 3-month follow-up
Volunteer firefighters' and their departments' perceived barriers in the development of reducing exposure and undertaking decontamination behaviors
Time Frame: Baseline, After 6 month intervention and 3-month follow-up
The data will be collected by an online survey: Firefighter Exposure to Carcinogens Scale . The dimensions will be rated on a a Likert scale. min :0 Max 4 ; The higher score does not mean a better outcome.
Baseline, After 6 month intervention and 3-month follow-up
Comparing and detecting any association between the regular volunteer firefighters and the management team towards cancer prevention
Time Frame: Baseline, After 6 month intervention and 3-month follow-up
The data will be collected by an online survey: Firefighter Exposure to Carcinogens Scale . The dimensions will be rated on a Likert scale. min :0 Max 4 ; The higher score does not mean a better outcome.
Baseline, After 6 month intervention and 3-month follow-up
Comparing characteristics of different volunteer Departments (Clusters) such as size and location of Department in terms of their future intention, current practice and perceived importance towards cancer prevention
Time Frame: Baseline, After 6 month intervention and 3-month follow-up
The data will be collected by an online survey: Firefighter Exposure to Carcinogens Scale . The dimensions will be rated on a Likert scale. min :0 Max 4 ; The higher score does not mean a better outcome.
Baseline, After 6 month intervention and 3-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
IWK Health Centre

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Laval University
Canadian Association of Fire Chiefs

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 13, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
October 30, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 30, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 16, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 16, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 27, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 20, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2025

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 1028192

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings